Call the infoline 800.452.2873
Understanding Pomalyst® (pomalidomide) capsules

Pomalyst in combination with dexamethasone was approved by the U.S. Food and Drug Administration (FDA) on February 8, 2013 for relapsed and refractory myeloma.
Configure this product
FREE
*